Want to join the conversation?
$INTC's 3Q15 revenue was up 10% from the prior quarter, and above the midpoint of its outlook. The higher than expected revenue growth was driven by higher notebook and desktop platform average selling prices, but YoverY revenue growth was flat.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?